07/11/2025
Why National Cancer Control Programme
The National Cancer Control Programme (NCCP) was launched in 1975 and later integrated into the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke (NPCDCS), which has been operational since 2010.
Moreover, in a significant step toward improving access to cancer treatments, three critical cancer medicines - Trastuzumab Deruxtecan, Osimertinib, and Durvalumab have been exempted from customs duty. These medicines are used to treat breast, lung, and biliary tract cancers, respectively, and their exemption has made it more affordable and accessible to patients.
Advances in Cancer Research and Treatment
While prevention is key, progress in cancer treatment is also critical. New approaches to cancer treatment are emerging, such as magnetic hyperthermia-based therapy, which uses magnetic nanoparticles to target and destroy tumor cells with minimal side effects. This method could revolutionize cancer treatment by reducing the need for traditional chemotherapy, which often comes with severe side effects. Research conducted by Indian scientists is contributing to the development of nanotherapy and other innovative treatments, making it possible to treat cancers more effectively and with fewer side effects.
